Manulife Offloads $3.2 Billion in Long-Term Care Risk to Munich Re — Manulife Financial Corporation

Event summary

$3.2 billion long-term care (LTC) reinsurance deal with Munich Re Life US, expected to close Q4 2026.
Third LTC reinsurance transaction in under three years; first on a standalone block.
Cumulative reduction of LTC morbidity sensitivity by 24% post-closing.
Transaction neutral to capital, with ~$30 million annual impact on core earnings, reducing over time.

The big picture

Manulife continues its multi-year effort to shed long-term care risk, a move aligned with industry trends toward reinsurance partnerships for capital optimization. The $3.2 billion transaction follows prior deals with Global Atlantic and RGA, reflecting a strategic pivot to reduce exposure in a volatile segment while maintaining financial stability.

What we're watching

Risk Reduction Strategy: Whether Manulife can sustain its aggressive LTC risk reduction strategy without disrupting core operations.
Regulatory Approvals: The pace at which regulatory approvals for the transaction will be finalized, given past deal timelines.
Capital Efficiency: How this deal impacts Manulife’s broader capital management strategy and shareholder value creation.